Ibogamine-18-carboxylic acid, 13-[(3α,20β)-19,20-dihydro-17-methoxy-17-oxovobasan-3-yl]-12-methoxy-, methyl ester
-
Ibogamine-18-carboxylic acid, 13-[(3α,20β)-19,20-dihydro-17-methoxy-17-oxovobasan-3-yl]-12-methoxy-, methyl ester
structure -
-
CAS No:
204581-20-4
-
Formula:
C43H54N4O5
-
Chemical Name:
Ibogamine-18-carboxylic acid, 13-[(3α,20β)-19,20-dihydro-17-methoxy-17-oxovobasan-3-yl]-12-methoxy-, methyl ester
-
Synonyms:
Ervadivaricatine B;204581-20-4;DTXSID40942632;Methyl 12-methoxy-13-(17-methoxy-17-oxo-19,20-dihydrovobasan-3-yl)ibogamine-18-carboxylate
-
CAS No:
Ibogamine-18-carboxylic acid, 13-[(3α,20β)-19,20-dihydro-17-methoxy-17-oxovobasan-3-yl]-12-methoxy-, methyl ester Basic Attributes
706.9 g/mol
706.40942084 g/mol
Computed Properties
Molecular Weight:706.9
XLogP3:6.9
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:8
Exact Mass:706.40942084
Monoisotopic Mass:706.40942084
Topological Polar Surface Area:99.9
Heavy Atom Count:52
Complexity:1350
Defined Atom Stereocenter Count:7
Undefined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
2-Cyclobutene-1-carboxylic acid, 4-(chlorocarbonyl)-, methyl ester, cis- (9CI)
139591-41-6
-
Cyclopropanecarboxylic acid, 1-formyl-2-methyl-, ethyl ester (9CI)
260261-27-6
-
Cyclopentanecarboxylic acid, 2-(hydroxyimino)-, methyl ester (9CI)
170016-09-8
-
Cyclopentanecarboxylic acid, 2-hydroxy-, methyl ester, (1R,2R)- (9CI) Formula
124150-22-7
-
Cyclopenta[b]pyrrole-2-carboxylic acid, octahydro-, methyl ester, [2R-(2-alpha-,3a-ba-,6a-ba-)]- (9CI) Formula
156557-90-3
-
3-Cyclopentene-1-carboxylic acid, 1-(chlorocarbonyl)-, ethyl ester (9CI) Formula
76910-09-3
-
Cyclohexanecarboxylic acid, 2-(acetylamino)-, methyl ester, cis- (9CI) Structure
193635-12-0
-
Cysteine, 2-methyl-, methyl ester (9CI) Structure
778548-47-3
-
What is 1,2-Benzenedicarboxylic acid, decyl isoundecyl ester
96507-80-1
-
What is Cyclopropanecarboxylic acid, 2-(1-methylethenyl)-, methyl ester, trans-(-)-
52148-73-9
Request for Quotation